Particle Counter Market Driven By Supportive Government Regulations for Effective Air Pollution Monitoring and Control

The Particle Counter Market is projected to reach USD 330.6 Million by 2021 from USD 275.9 Million in 2016, at a CAGR of 3.7%. Growing pharmaceutical and semiconductor industries, increasing spending on pharmaceutical R&D, and growth in manufacturing industries in emerging nations are key factors driving the market growth for particle counters.

Get PDF Brochure Here : http://bit.ly/2vWaLLf

Key players :

Particle Measuring Systems (U.S.), Beckman Coulter (U.K.), RION Co., Ltd (Japan), Lighthouse Worldwide Solutions (U.S.), TSI (U.S.), and Climet Instruments Company (U.S.) are some of the key players in the global Particle Counter Market .

Geography :

The particle counters market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and RoW. Among these regional segments, North America is expected to account for the largest share of the global market in 2016. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

About Report :

The global market is segmented on the basis of type, application, end user, and region. On the basis of type, the global market is segmented into airborne and liquid particle counters. The airborne particle counters segment is further categorized into portable, remote, handheld, and condensation particle counters. In 2016, the portable particle counters segment is expected to account for the largest share of the airborne market. 

On the basis of application, the market is segmented into cleanroom monitoring, air quality monitoring, contamination monitoring of liquids, drinking water application, aerosol monitoring and research, chemical contamination monitoring, and other applications.

To Know More : http://bit.ly/2vVSeif

BRIC IVD Market Research Methodology Focuses On Exploring Major Factors Influencing the Industry Development

 Factors driving the IVD Market in BRIC

1.      Rising aging population with a related increase in chronic diseases,

2.      Increasing healthcare expenditure

3.      Rise in demand for point-of-care testing.

Get PDF Brochure Here :http://bit.ly/2uPSEpB

The in vitro diagnostics (IVD) market in BRIC is estimated to reach USD 15.71 billion by 2022, at a CAGR of 8.2% during the forecast period.

Market Geography:

In 2016, China commanded the largest share of the IVD market in BRIC, followed by Brazil. China is also expected to register the highest growth during the forecast period. The high growth in the Chinese market can be attributed to large population & rapid growth in overall patient population, rising healthcare needs, improving healthcare infrastructure, and increasing income of the middle-class population.

About Report :

In this report, the market is segmented by product & service, technology, application, end user, and country. The IVD market in BRIC by product and service are broadly categorized into four major segments—reagents & kits, instruments, services, and data management software.

 Among these, the reagents & kits segment accounted for the largest share of the market in 2016. This is primarily attributed to the increased accessibility and demand for reagents, the rising number of IVD tests conducted, and the increased variety of reagents available. The reagents & kits segment is also expected to register the highest growth in the market mainly due to the analytical techniques employed and the continuous launch of new, faster, & reliable IVD products.

Based on technology, the market is broadly segmented into immunoassays/immunochemistry, clinical chemistry, molecular diagnostics, hematology, clinical microbiology, coagulation & hemostasis, and other technologies. The molecular diagnostics segment is estimated to register the highest CAGR during the forecast period of 2017 to 2022. The rising prevalence of infectious diseases, cancer, and various genetic disorders; growing demand for blood screening; and increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing is expected to drive the growth of the market during the forecast period.

To Know More : http://bit.ly/2vnQWxb

The Environmental Monitoring Industry Is An Attractive Market For Innovative Pollution Monitoring Products

Major Factors Driving The Growth Of Environmental Monitoring Market

·       1.  Increasing government initiatives to control environmental pollution levels

·       2.  Increasing Government Funding For Pollution Control And Monitoring

·       3.  Ongoing installations of environment monitoring stations

·       4.  Growing initiatives for the development of environment-friendly industries 

Get PDF Brochure Here  : http://bit.ly/2hFlLHD

The global environmental monitoring market is expected to reach USD 19.56 Billion by 2021, growing at a CAGR of 7.7% during the forecast period. 

Key players :

Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Honeywell International Inc. (U.S.), Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), TE Connectivity Ltd. (Switzerland), General Electric Company (U.S.), Emerson Electric Co. (U.S.), Teledyne Technologies Inc. (U.S.), and Merck KGaA (Germany)are some key players operating in the global market.

Market Geography :

The Asia-Pacific market is projected to grow at the highest CAGR of 10.0% during the forecast period. Increasing industrialization in Asia-Pacific countries (such as China and India), implementation of increasingly stringent environmental regulation policies, and the growing need to comply with various environmental safety regulations are the key factors propelling the demand for Environmental Monitoring products in emerging nations. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

About Market

On the basis of applications (temperature sensing, moisture detection, chemical detection, biological detection, particulate detection, and noise measurement. On the basis of product, the global environmental monitoring market is divided into three major categories, namely, environmental monitors, environmental sensors, and environmental monitoring software.

To Know More About It : http://bit.ly/2eS6bHE

Global Orthopedic Braces & Support Market Growth Is Driven by Increasing Number of Orthopedic Knee Surgeries

Download PDF  Brochure: https://tinyurl.com/y7t6zbh7

The growing demand for orthopedic support system can be attributed to a number of factors, such as the rising aging population, rising awareness about the orthopedic support systems among the people, and increasing cases of road accidents and sports injuries and co-morbid conditions leading to orthopedic disorders or diseases.

The global orthopedic braces & support market was valued at USD 3.2 Billion in 2014 and is expected to reach USD 4.3 Billion by 2020, at a CAGR of 5.0% from 2015 to 2020.

Key players :

Some of the major players in the orthopedic braces market include Bauerfeind AG (Germany) Breg, Inc. (U.S.) DeRoyal Industries, Inc. (U.S.), DJO Global (U.S.), Ossur (Iceland), Ottobock (Germany), and BSN Medical (Germany).

Geography:

The global orthopedic braces market has been categorized into major geographical regions, including Europe, North America, Asia, and Rest of the world. North America is the most dominant region in the global orthopedic braces market, and contributed a share of 47.4% in 2014; the market in this region was valued at USD 1.5 billion in the same year.

Download Sample Report :

https://tinyurl.com/y95ageds

Orthopedic braces and supports are devices that are used to support and strengthen muscles and joints. These are used in prophylaxis of injury and patient care settings, right from the emergency room through the hospitalization period to rehabilitation and after care. Ligament injuries are one of the most common injuries in any sport; thus, braces and support systems are used to treat knee & ankle sprains, torn knee ligaments, and so on.

Computerized Physician Order Entry Market Global Trends & Forecast to 2019

Features Of Computerized Physician Order Entry

CPOE is an electronic entry process utilized by medical practitioners to enter medication orders and other treatment related instructions particularly for hospitalized patients under care. It reduces errors related to handwriting as well as reduces the time taken for order completion. The order entry is transmitted over a network to various departments within a hospital, including pharmacy, laboratory, and radiology.  

The global computerized physician order entry (CPOE) market was valued at $999.9 Million in 2014,and Computerized Physician Order Entry Market worth 379 Million USD by 2019, and is projected to grow at a CAGR of 6.6% during the forecast period from 2014 to 2019.

                                      

Get PDF  Brochure Here :http://bit.ly/2uxzd5g

Key players :

The key players profiled in the global CPOE market are Allscripts (U.S.), Athenahealth, Inc. (U.S.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Medical Information Technology, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks LLC (U.S.), Epic systems (U.S.), GE healthcare (U.K.), Mckesson Corporation (U.S.), and Carestream Health (U.S.). 

Market Geography:

The market, on the basis of region, has been classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. North America held the largest share of 59.5% in the total global CPOE market, which was followed by Europe. The rising number of installations in North America is due to the high adoption of advanced technology, wherein a greater emphasis is laid on hospital automation.

About Report :

The global CPOE Market has been segmented on the basis of five categories, namely, type, component, deployment, end-user, and region. On the basis of type, the market is segmented into integrated CPOE and standalone CPOE, wherein the integrated CPOE sub-segment dominated the global CPOE market with a share of 75.0% in 2014.

On the basis of component, this market is further divided into services, software, and hardware, wherein the services sub-segment has the largest market value. On the basis of deployment, this market is segmented into web-based, on premise, and cloud based, wherein the web-based sub-segment has the largest market value. 

To Know More : Click Here

Global Fully Integrated Pharmacovigilance Software Market Global Forecast to 2019

The global pharmacovigilance and drug safety software market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $154.1 Million in 2019.

Download PDF Brochure : http://bit.ly/2v2EZfU

In this report, the global pharmacovigilance and drug safety software market has been classified into many segments on the basis of functionality, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. 

The global pharmacovigilance and drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. The global pharmacovigilance and drug safety software market is also segmented on the basis of end users including pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers.

Market Key players :

ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players in the global pharmacovigilance and drug safety software market.

Market Geography :

As of 2014, North America holds the largest share of the global pharmacovigilance and drug safety software market, followed by Europe. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations.

To Know More : Click Here

Increasing Demand For Minimally Invasive Angioplasty Treatments Driving Global Interventional Cardiology And Peripheral Vascular Devices Market

Factors such as the aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are expected to drive the growth of this market.The interventional cardiology market is expected to reach USD 31.47 Billion by 2021 from USD 21.83 Billion in 2016, at a CAGR of 7.1%.

Get PDF Brochure Here: http://bit.ly/2uDGzna

Key players :

The major players in the interventional cardiology market include Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).

About Report :

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

Value Addition for the Buyer:

This report aims to provide insights into the global interventional cardiology & peripheral vascular devices market. It provides valuable information on interventional cardiology & peripheral vascular devices product segment and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.

To Know More About It: http://bit.ly/2uE8eog 

Increasing Demand For Standard-Based Medical Image Archiving And Non-Dicom Content Management | Driving Vendor Neutral Archive (VNA) Market

Get PDF Brochure Here : http://bit.ly/2hqdozC

Vendor Neutral Archive (VNA) Technology Benefits :

VNAs enable the acquisition, management, and storage of images while streamlining the communication between multiple vendor PACS. while streamlining the communication between multiple vendor  Picture Archiving And Communications System (PACS).

The global VNA market is poised to reach $335 million by 2018, at a healthy double-digit CAGR; whereas, the PACS market is growing at a steady CAGR of 5.8%, to reach $4.3 billion by 2018.

About Report :

The VNA market is segmented on the basis of its delivery mode, deployment model, and supplier type. In the delivery mode segment, on-premise VNA forms the largest segment of the overall VNA market, as on premise VNAs are perceived to offer better control and secure sharing of data. However, Hybrid VNA will be the fastest growing and consequently a new revenue generating segment for players in this market. Hybrid VNAs allow the cloud to store all the second copies of images, thereby significantly reducing the cost of disaster recovery.

The Major Factor Driving Growth :

A number of factors such as the presence of favorable government regulations for top markets and the growing demand for standard based storage, disaster recovery, and lifecycle management solutions are propelling the growth of the market for VNAs. Consolidation of patient information by integrating VNAs with electronic health records (EHR) is one of the important trends witnessed in this market

To Know More : http://bit.ly/2uZ5ykU

Healthcare Quality Management Software: Market Overview

The Major Factor For The Market Growth :

Government mandates for healthcare providers to report quality & improve the performance of care provided, rising healthcare costs, high rate of medication errors, growing need to minimize hospital readmissions, and increase in the volume of unstructured data in the healthcare industry are the major factors driving the growth of the market.

Get PDF Brochure Here : http://bit.ly/2wrejCk

The global healthcare quality management market is projected to reach USD 3.31 billion by 2022 from an estimated USD 1.70 billion in 2017, at a CAGR of 14.2%.

On the basis of type, the business intelligence & analytic solutions segment is the fastest-growing segment during the forecast period. The soaring operating costs, rising demand for quality healthcare, government measures to promote value-based care, and the increasing number of claims denied from insurers are the major factors driving the growth of the business intelligence & analytic solutions segment.

By delivery mode, the global healthcare quality management market is segmented into web-& cloud-based and on-premise solutions. In 2016, the web-& cloud-based solutions segment dominated the healthcare quality management market. This segment is also expected to grow at the highest CAGR during the forecast period. The flexibility of working from remote areas, affordability, and automated updating features are some of the factors attributing to the high growth of the web- & cloud-based solutions segment.

On the basis of application, the market is categorized into data management and risk management. In 2016, the data management segment accounted for the largest share of the healthcare quality management market. The large share of this segment is attributed to the increasing volume of disparate data and the requirement of quality-based reports by regulatory bodies. The data management segment is further divided into unstructured data abstraction, data processing & analysis, report generation, and report submission. In 2016, the data processing & analysis segment accounted for the highest share of the data management market. The large share of this segment is mainly attributed to the high volume of unwanted data generation by healthcare facilities and growing need to structure & analyze data in a standardized format for quality reporting.

North America is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the growing healthcare IT spending, developed infrastructure, evolving regulations for better healthcare outcomes, and the presence of prominent market players in this region.

To Know More : http://bit.ly/2wdqJOY

Increasing Focus on Personalized Medicine to Boost the Nuclear Imaging Market Growth

The report"Nuclear Imaging Equipment Market by Product (SPECT (Hybrid SPECT, Standalone SPECT), Hybrid PET, & Planar Scintigraphy), Application (Oncology, Cardiology & Neurology) & End user (Hospitals, Imaging Centers) - Global Forecasts to 2021", that analyzes and studies the major market drivers, restraints/challenges, and opportunities.

This report studies the global nuclear imaging equipment market for the forecast period of 2016 to 2021. This market is expected to reach USD 2.85 Billion by 2021 from USD 2.25 Billion in 2016, growing at a CAGR of 4.8%.

The global nuclear imaging equipment market is segmented on the basis of product, application, end user, and region.

Based on product, the nuclear imaging equipment market is categorized into SPECT systems, hybrid PET systems, and planar scintigraphy.

 In 2016, the SPECT systems segment is expected to account for the largest share of the nuclear imaging equipment market. The SPECT systems are further segmented into hybrid SPECT and standalone SPECT systems. In 2016, the hybrid SPECT segment is expected to account for the largest share of the SPECT nuclear imaging equipment market. Advantages such as better imaging ability, high resolution, and the ability to show molecular processes in vivo render hybrid SPECT systems superior than standalone systems.

Get PDF Brochure Here : http://www.marketsandmarkets.com/pdfdownload.asp?id=98

Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology). In 2016, the oncology application segment is expected to account for the largest share of the nuclear imaging equipment applications market. The rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the same, and development of advanced systems and radiotracers for oncology are the key factors contributing to the large share of the oncology segment.

Based on end user, the nuclear imaging market is segmented into hospitals, imaging centers, academic & research centers, and other end users (pharmaceutical & biotechnology companies and CROs). In 2016, the hospitals segment is expected to account for the largest share of the market. The rise in the use of advanced imaging solutions and hybrid imaging systems in hospitals and enhanced care quality is driving the growth of this segment.

Based on region, the nuclear imaging equipment market is divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The RoW region comprises Latin America, the Middle East and Africa. In 2016, North America is projected to account for the largest share of the nuclear imaging equipment market, followed by Asia-Pacific and Europe. Increase in adoption of nuclear imaging technologies and rapid growth in aging population, along with high incidence and prevalence of chronic diseases, are propelling the growth of the North American nuclear imaging equipment market.

Factors driving the global market include introduction of new and advanced products, investment for the modernization of diagnostic imaging centers, development of new radiotracers, and increasing incidence and prevalence of cancer & cardiovascular diseases. However, factors such as shutdown of National Research Universal (NRU) reactor, high cost of nuclear imaging equipment, and shorter half-life of radiopharmaceuticals are hindering the growth of the market.

Get Request Sample Here : http://www.marketsandmarkets.com/requestsample.asp?id=98

The major players in the global nuclear imaging equipment market are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.S.).These companies are dominant in the nuclear imaging market mainly due to their well-established presence in the field of medical imaging, presence in over 50 countries, high R&D investments, and strong sales and distribution force.

 The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (U.S.), CMR Naviscan Corporation (U.S.), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

Attractive Growth Opportunities in Orthopedic Software Market During 2012–2020

Factors Which Are Driving Orthopedic Software Market 

Growing aging population, upsurge in the number of orthopedic surgeries, and rising incidences of orthopedic problems such as arthritis and osteoporosis are some of the factors propelling the growth of this market. Rising incidences of lifestyle disorders like obesity is another factor leading to orthopedic problems among patients, which is further expected to aid the growth of this market.

The orthopedic software market is expected to grow at a CAGR of 5.1% from 2014 to 2020 to reach $308.5 million by 2020.

Get PDF Brochure Here : http://bit.ly/2vRKTks

Key players :

Materialise NV (Belgium), Merge Healthcare Inc. (U.S.), Brainlab AG (Germany), CureMD (U.S.), HealthFusion Inc. (U.S.), Medstrat, Inc. (U.S.), McKesson Corporation (U.S.), and Greenway Health (U.S.) are some of the leading players in this market.

Market Geography:

The North American market accounted for the largest share of the global market in 2014, followed by Europe, Asia-Pacific, and Rest of the World (RoW). This is mainly due to the relatively high penetration of orthopedic software in North America as compared to Europe, Asia-Pacific and RoW. However, Asia-Pacific region is expected to register highest growth during the forecast period owing to increasing acceptance of healthcare IT in this region. China and Japan are some of the countries that are expected to contribute to the growth of this region.

About Report :

The global market is broadly segmented into products, applications, and mode of delivery. By type of products, this market is mainly sub-segmented into pre-operative planning software, orthopedic EHR, practice management, orthopedic picture archiving and communication systems (PACS), and orthopedics revenue cycle management (RCM). The market by applications covers orthopedic surgeries, joint replacement, fracture and limb deformity management, and pediatric assessment; while the market by mode of delivery covers web-based, cloud based, and on premises systems.

To Know More : http://bit.ly/2vHb5ho

HIP Replacement Market worth 5.9 Billion USD by 2020

This global hip reconstruction devices market is analysed and segmented on the basis of product, and region. It analyzes the competitive developments, such as alliance, joint venture, and mergers & acquisitions in the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments.

A hip replacement is an invasive surgical procedure, used to remove a diseased or fractured hip joint and replace it with an artificial joint or prosthesis. Osteoarthritis is one of the most common factors for hip diseases. Structures within the hip (such as the cartilage or bony joint surfaces) may get damaged due to overuse, trauma, or certain conditions, such as rheumatoid arthritis, tumors, and so on. This may lead to degenerative changes within the hip which can lead to 

osteoarthritis.

Get PDF Brochure Here : http://bit.ly/2wS7j2k

Some of the significant factors of the MIS are reduced hospital stay, as well as shortened rehabilitation time. Also, the increasing number of patients suffering from osteoarthritis, rheumatoid arthritis, and osteoporosis have led to increase in the adoption rate of hip surgeries in both geriatric as well as young population. Out of 66 million population of France, about 3% of the population is aged above 65 years, and has undergone hip replacement/reconstruction.

The global hip reconstruction devices market was valued at USD 4.8 Billion in 2014 and is expected to reach USD 5.9 Billion by 2020, at a CAGR of 3.0% from 2015-2020.

The hip reconstruction devices market is broadly segmented on the basis of product and geography. Based on product, the global market is classified into primary, partial, revision and hip resurfacing devices. The primary is subsegmented into cementless and cemented reconstruction device. The primary devices commands the largest share in the market, by product.

The report provides a detailed analysis of hip reconstruction devices market for each region and country. Four major regions have been covered in the report, such as North America (the U.S., Canada, Mexico, Brazil, Argentina, Chile, Columbia, Uruguay and Paraguay); Europe (Germany, France, Italy, Spain, Switzerland, the U.K., Netherlands, Belgium, Denmark, Turkey, and Russia); and Asia-Pacific (Japan, China, India, Australia, Republic of Korea, Singapore, Malaysia, New Zealand, Vietnam, Indonesia, Taiwan, and Thailand). A deep-dive analysis on pricing pattern, usage pattern, end user response matrix, market share, government initiatives, product recalls, new product launches, industry trends, and technological advancements have been detailed in the report.

The report also covers the competitive landscape of global hip reconstruction devices market by new product launches, recent developments, and mergers & acquisitions. The major players operating in this market are Zimmer Inc. (U.S.), DePuy Synthes (U.S.), Stryker (U.K.), and Smith & Nephew (U.K.), B. Braun Melsungen AG (Germany), Corin (U.K.), and Waldemar LINK GmbH & Co. KG (Germany).

To Know More : http://bit.ly/2uKs4jk

Increasing Prevalence of Lifestyle Diseases | Driving Vascular Access Devices Market

The global vascular access devices market is expected to reach USD 5.45 billion by 2022 from USD 3.87 billion in 2017, at a CAGR of 7.1%.

The major drivers for the market

·         Growing prevalence of lifestyle diseases

·         An increase in the number of chemotherapy procedures

·         The increasing use of vascular access devices in pediatric patients.

Get PDF Brochure Here : http://bit.ly/2tYSEAL

The report analyzes the vascular access device market by type, application, end user, and region. The type segment includes central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is expected to account for the largest share of the vascular access devices market in 2017. The dominant share of the market is attributed to the fact that central vascular access devices are used in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

By type, the market segment is segmented into central vascular access devices, peripheral vascular access devices, and accessories. Central vascular access devices are expected to account for the largest share of the market in 2017. The growth of this segment is attributed to the wide usage of central vascular access devices in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.

 Based on application, the market is broadly classified into drug administration, fluids and nutrition administration, blood transfusion, and diagnostics and testing. The drug administration segment is estimated to account for the largest share of the market in 2017, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.

Based on the end users, the market is segmented into hospitals, clinics and ambulatory care centers, and other end users. In 2017, the hospital segment is expected to dominate this market. The large share of this segment can be attributed to the fact that a majority of vascular procedures are performed in hospital settings.

To Know More : http://bit.ly/2f7R64N